Ischemic heart disease, non-ischemic cardiomyopathies, inflammatory heart diseases and structural heart diseases including subclinical myocardial alterations I00-I99
Conditions
Interventions
Group 1: This is a retrospective, non-randomized observational study. Patients who underwent cardiac magnetic resonance imaging at Heidelberg University Hospital between 2005 and 2007 are included. De
Sponsors
Universitätsklinikum Heidelberg - Innere Medizin 3
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who underwent cardiac magnetic resonance imaging at Heidelberg University Hospital between 2005 and 2007 are eligible for inclusion. Availability of relevant imaging datasets and baseline clinical data at the time of examination is required. In addition, availability of follow-up data must be ensured. In addition, healthy participants from the Heidelberg site of the Healthy Hearts Consortium are included as a control group.
Exclusion criteria
Exclusion criteria: Patients are excluded in case of incomplete datasets, particularly when essential imaging or clinical information is missing. Furthermore, cases without available follow-up data and examinations with insufficient image quality precluding reliable analysis are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is all-cause mortality. Outcome assessment is performed via official registry data (residents’ registration office) at the end of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints include the occurrence of major adverse cardiovascular events (MACE), defined as myocardial infarction, stroke, or cardiovascular death. In addition, time to revascularization (percutaneous coronary intervention or coronary artery bypass grafting) and cardiovascular-related hospitalization are assessed. | — |
Countries
Germany
Contacts
Public ContactLukas Weberling
Universitätsklinikum Heidelberg - Innere Medizin 3
Outcome results
None listed